Research ArticleCELL BIOLOGY

Identification of the hyaluronic acid pathway as a therapeutic target for facioscapulohumeral muscular dystrophy

See allHide authors and affiliations

Science Advances  11 Dec 2019:
Vol. 5, no. 12, eaaw7099
DOI: 10.1126/sciadv.aaw7099

Article Information

vol. 5 no. 12

Online ISSN: 
History: 
  • Received for publication January 18, 2019
  • Accepted for publication October 23, 2019
  • .

Author Information

  1. Alec M. DeSimone1,
  2. John Leszyk2,
  3. Kathryn R. Wagner3 and
  4. Charles P. Emerson Jr.1,*
  1. 1Wellstone Muscular Dystrophy Program, Department of Neurology, University of Massachusetts Medical School, Worcester, MA, USA.
  2. 2Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, USA.
  3. 3Center for Genetic Muscle Disorders, Kennedy Krieger Institute, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  1. *Corresponding author. Email: charles.emersonjr{at}umassmed.edu

Altmetric

Article usage

Article usage: December 2019 to May 2021

AbstractFullPdf
Dec 20193563260442
Jan 20201837285
Feb 20201044676
Mar 20201021762
Apr 2020916474
May 2020216354
Jun 20201316245
Jul 2020311617
Aug 202058534
Sep 20201214640
Oct 20201015178
Nov 2020910843
Dec 20201412423
Jan 202178937
Feb 20211510125
Mar 20212111439
Apr 20211612521
May 20211215516

Stay Connected to Science Advances

Navigate This Article